1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Wet AMD 1.4.3 Dry AMD 1.5 Market by Application 1.5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Research Institute 1.5.5 Other 1.6 Coronavirus Disease 2019 (Covid-19): Age-Related Macular Degeneration (AMD) Therapeutics Industry Impact 1.6.1 How the Covid-19 is Affecting the Age-Related Macular Degeneration (AMD) Therapeutics Industry 1.6.1.1 Age-Related Macular Degeneration (AMD) Therapeutics Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Age-Related Macular Degeneration (AMD) Therapeutics Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Age-Related Macular Degeneration (AMD) Therapeutics Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Perspective (2015-2026) 2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions 2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Age-Related Macular Degeneration (AMD) Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Market Size 3.1.1 Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio 3.2.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019 3.3 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served 3.4 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service 3.5 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Type (2021-2026) 5 Age-Related Macular Degeneration (AMD) Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 5.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020) 6.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in North America (2019-2020) 6.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) 6.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020) 7.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) 7.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020) 8.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in China (2019-2020) 8.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) 8.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020) 9.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) 9.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020) 10.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020) 11.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in India (2019-2020) 11.3 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) 11.4 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2015-2020) 12.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Amgen Inc. 13.1.1 Amgen Inc. Company Details 13.1.2 Amgen Inc. Business Overview and Its Total Revenue 13.1.3 Amgen Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction 13.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020)) 13.1.5 Amgen Inc. Recent Development 13.2 Bausch Health Companies, Inc. 13.2.1 Bausch Health Companies, Inc. Company Details 13.2.2 Bausch Health Companies, Inc. Business Overview and Its Total Revenue 13.2.3 Bausch Health Companies, Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction 13.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) 13.2.5 Bausch Health Companies, Inc. Recent Development 13.3 F. Hoffmann-La Roche Ltd. 13.3.1 F. Hoffmann-La Roche Ltd. Company Details 13.3.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue 13.3.3 F. Hoffmann-La Roche Ltd. Age-Related Macular Degeneration (AMD) Therapeutics Introduction 13.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) 13.3.5 F. Hoffmann-La Roche Ltd. Recent Development 13.4 Novartis AG 13.4.1 Novartis AG Company Details 13.4.2 Novartis AG Business Overview and Its Total Revenue 13.4.3 Novartis AG Age-Related Macular Degeneration (AMD) Therapeutics Introduction 13.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) 13.4.5 Novartis AG Recent Development 13.5 Regeneron Pharmaceuticals Inc. 13.5.1 Regeneron Pharmaceuticals Inc. Company Details 13.5.2 Regeneron Pharmaceuticals Inc. Business Overview and Its Total Revenue 13.5.3 Regeneron Pharmaceuticals Inc. Age-Related Macular Degeneration (AMD) Therapeutics Introduction 13.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) 13.5.5 Regeneron Pharmaceuticals Inc. Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Age-Related Macular Degeneration (AMD) Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Age-Related Macular Degeneration (AMD) Therapeutics Revenue Table 3. Ranking of Global Top Age-Related Macular Degeneration (AMD) Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Wet AMD Table 6. Key Players of Dry AMD Table 7. COVID-19 Impact Global Market: (Four Age-Related Macular Degeneration (AMD) Therapeutics Market Size Forecast Scenarios) Table 8. Opportunities and Trends for Age-Related Macular Degeneration (AMD) Therapeutics Players in the COVID-19 Landscape Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 10. Key Regions/Countries Measures against Covid-19 Impact Table 11. Proposal for Age-Related Macular Degeneration (AMD) Therapeutics Players to Combat Covid-19 Impact Table 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 13. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 15. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2015-2020) Table 16. Global Age-Related Macular Degeneration (AMD) Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 17. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026) Table 18. Market Top Trends Table 19. Key Drivers: Impact Analysis Table 20. Key Challenges Table 21. Age-Related Macular Degeneration (AMD) Therapeutics Market Growth Strategy Table 22. Main Points Interviewed from Key Age-Related Macular Degeneration (AMD) Therapeutics Players Table 23. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by Players (2015-2020) (Million US$) Table 24. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players (2015-2020) Table 25. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019) Table 26. Global Age-Related Macular Degeneration (AMD) Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 27. Key Players Headquarters and Area Served Table 28. Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product Solution and Service Table 29. Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market Table 30. Mergers & Acquisitions, Expansion Plans Table 31. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 32. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Type (2015-2020) Table 33. Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by Type (2021-2026) Table 34. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2015-2020) Table 35. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 36. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Share by Application (2021-2026) Table 37. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$) Table 38. North America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020) Table 39. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 40. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020) Table 41. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 42. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020) Table 43. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$) Table 44. Europe Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020) Table 45. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 46. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020) Table 47. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 48. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020) Table 49. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$) Table 50. China Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020) Table 51. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 52. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020) Table 53. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 54. China Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020) Table 55. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$) Table 56. Japan Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020) Table 57. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 58. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020) Table 59. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 60. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020) Table 61. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$) Table 62. Southeast Asia Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020) Table 63. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 64. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020) Table 65. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 66. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020) Table 67. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$) Table 68. India Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020) Table 69. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 70. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020) Table 71. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 72. India Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020) Table 73. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Revenue (2019-2020) (Million US$) Table 74. Central & South America Key Players Age-Related Macular Degeneration (AMD) Therapeutics Market Share (2019-2020) Table 75. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2015-2020) (Million US$) Table 76. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type (2015-2020) Table 77. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2015-2020) (Million US$) Table 78. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2015-2020) Table 79. Amgen Inc. Company Details Table 80. Amgen Inc. Business Overview Table 81. Amgen Inc. Product Table 82. Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$) Table 83. Amgen Inc. Recent Development Table 84. Bausch Health Companies, Inc. Company Details Table 85. Bausch Health Companies, Inc. Business Overview Table 86. Bausch Health Companies, Inc. Product Table 87. Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$) Table 88. Bausch Health Companies, Inc. Recent Development Table 89. F. Hoffmann-La Roche Ltd. Company Details Table 90. F. Hoffmann-La Roche Ltd. Business Overview Table 91. F. Hoffmann-La Roche Ltd. Product Table 92. F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$) Table 93. F. Hoffmann-La Roche Ltd. Recent Development Table 94. Novartis AG Company Details Table 95. Novartis AG Business Overview Table 96. Novartis AG Product Table 97. Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$) Table 98. Novartis AG Recent Development Table 99. Regeneron Pharmaceuticals Inc. Company Details Table 100. Regeneron Pharmaceuticals Inc. Business Overview Table 101. Regeneron Pharmaceuticals Inc. Product Table 102. Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) (Million US$) Table 103. Regeneron Pharmaceuticals Inc. Recent Development Table 104. Research Programs/Design for This Report Table 105. Key Data Information from Secondary Sources Table 106. Key Data Information from Primary Sources List of Figures Figure 1. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Wet AMD Features Figure 3. Dry AMD Features Figure 4. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Hospital Case Studies Figure 6. Clinic Case Studies Figure 7. Research Institute Case Studies Figure 8. Other Case Studies Figure 9. Age-Related Macular Degeneration (AMD) Therapeutics Report Years Considered Figure 10. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions: 2020 VS 2026 Figure 12. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Players in 2019 Figure 15. Global Top Age-Related Macular Degeneration (AMD) Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Age-Related Macular Degeneration (AMD) Therapeutics as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Age-Related Macular Degeneration (AMD) Therapeutics Revenue in 2019 Figure 17. North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Amgen Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Amgen Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) Figure 26. Bausch Health Companies, Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Bausch Health Companies, Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) Figure 28. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) Figure 30. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Novartis AG Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) Figure 32. Regeneron Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Regeneron Pharmaceuticals Inc. Revenue Growth Rate in Age-Related Macular Degeneration (AMD) Therapeutics Business (2015-2020) Figure 34. Bottom-up and Top-down Approaches for This Report Figure 35. Data Triangulation Figure 36. Key Executives Interviewed

Amgen Inc. Bausch Health Companies, Inc. F. Hoffmann-La Roche Ltd. Novartis AG Regeneron Pharmaceuticals Inc.